Mechanism of action
The future of rectal spacing has arrived. Watch the video to see what sets Barrigel apart.
How Barrigel Works VideoTranscript
Barrigel is the first and only sculptable rectal spacer protecting the rectal wall during radiation therapy for prostate cancer.
What makes Barrigel different?
It all starts with Barrigel's non-polymerizing composition designed to give you the control you need and the customizable coverage you want.
Barrigel is made from non-animal stabilized hyaluronic acid known as NASHA, a material proven safe and effective for over 20 years in more than 50 million procedures worldwide.
Barrigel’s internal structure provides both sculptability and lift, making it an ideal material for rectal spacing. Every anatomy is different and deserves a customized implant.
An advantage of Barrigel is it allows the precision necessary to achieve the optimal placement in every patient.
Throughout the procedure, Barrigel allows you to sculpt the shape of the implant.
With its hyperechoic properties that ensure high visibility on TRUS, you have a clear view of Barrigel as you sculpt the implant in real time.
This protects the rectal wall and provides adequate lateral coverage from apex to base.
Because Barrigel does not polymerize or harden, additional material may be placed where needed to achieve optimal coverage.
Barrigel: sculptable control for customizable coverage.
Every aspect of Barrigel was created with a focus on optimizing the implant experience and outcome. The unique, sculptable formulation offers the unprecedented control and coverage you seek. And the protection your patients need.1
Say goodbye to complex kits. Barrigel comes ready to use with a single-step assembly process (needle attachment). Once you attach the needle to the syringe, it is ready for deployment, reducing preparation time and the potential for expensive assembly errors.
Join the future
of rectal spacing
To start using Barrigel, request enrollment in
the Barrigel Training Program.
- Mariados NF, Orio PF, Schiffman Z, et al. Hyaluronic acid spacer for hypofractionated prostate radiation therapy: a randomized clinical trial. JAMA Oncol. 2023;e1-e8.